Treatment of Hypertension Reduces Cognitive Decline in Older Adults: a Systematic Review and Meta-analysis

Overview

Journal BMJ Open

Specialty General Medicine

Date 2020 Nov 18

PMID 33203630

Citations 19

Authors

Aditi Gupta

Sophy Perdomo

Sandra Billinger

Srinivasan Beddhu

Jeffrey Burns

Gary Gronseth

Affiliations

Soon will be listed here.

Abstract

Objectives: To systematically analyse the effect of pharmacological treatment of hypertension (HTN) on cognitive decline in older adults.

Methods: Randomised, placebo-controlled trials with a prespecified quantitative outcome of cognition and a pharmacological intervention for at least 12 months to treat HTN in older adults (>60 years). Our primary outcome was change in cognition with pharmacological treatment of HTN. Standardised mean difference (SMD) was used to analyse different outcomes reported in the selected studies. We searched PubMed CENTRAL and the Cochrane Library from inception to 6 July 2020. Two independent reviewers assessed trial quality and extracted data. Internal and external validity of the studies was assessed.

Results: Nine randomised controlled trials with 34 994 participants were included in the final analysis. The net SMD for change in cognition was -0.049 (CI: -0.078 to -0.019) indicating that treatment of HTN decreased cognitive decline. Heterogeneity was low with an I² of 6%.

Discussion: Current evidence does not indicate worsening of cognition with treatment of HTN. Treatment of HTN in older adults may reduce cognitive decline. These results have important implications in clinical management of patients at risk for dementia.

Prospero Registration Number: CRD42020139750.

Citing Articles

Dietary fibre and the gut-brain axis: microbiota-dependent and independent mechanisms of action.

La Torre D, Verbeke K, Dalile B Gut Microbiome (Camb). 2024; 2:e3.

PMID: 39296317 PMC: 11406392. DOI: 10.1017/gmb.2021.3.

The Impact of Hypertension on Cognitive Decline and Alzheimer's Disease and Its Management: A Systematic Review.

Khan A, Elnagar S, Eltayeb M, Baluch S, Kumar A, Kumari M Cureus. 2024; 16(7):e65194.

PMID: 39176335 PMC: 11340657. DOI: 10.7759/cureus.65194.

The Association Between Type of Insurance Plan, Out-of-Pocket Cost, and Adherence to Antihypertensive Medications in Medicare Supplement Insurance Enrollees.

Zhang D, Xu J, Hall D, Chen X, Chen M, Divers J Am J Hypertens. 2024; 37(8):631-639.

PMID: 38727326 PMC: 11247132. DOI: 10.1093/ajh/hpae062.

Antihypertensive medication in frail older adults: A narrative review through a deprescribing lens.

Kraut R, Lundby C, Babenko O, Kamal A, Sadowski C Am Heart J Plus. 2024; 17:100166.

PMID: 38559885 PMC: 10978346. DOI: 10.1016/j.ahjo.2022.100166.

Current perspectives on prevention of vascular cognitive impairment and promotion of vascular brain health.

Kalaria R, Akinyemi R, Paddick S, Ihara M Expert Rev Neurother. 2023; 24(1):25-44.

PMID: 37916306 PMC: 10872925. DOI: 10.1080/14737175.2023.2273393.

References

McGuinness B, Todd S, Passmore P, Bullock R . Blood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitive impairment and dementia. Cochrane Database Syst Rev. 2009; (4):CD004034. PMC: 7163274. DOI: 10.1002/14651858.CD004034.pub3. View

Hankey G, GUBBAY S . Focal cerebral ischaemia and infarction due to antihypertensive therapy. Med J Aust. 1987; 146(8):412-4. DOI: 10.5694/j.1326-5377.1987.tb120332.x. View

Qiu C, Winblad B, Fratiglioni L . The age-dependent relation of blood pressure to cognitive function and dementia. Lancet Neurol. 2005; 4(8):487-99. DOI: 10.1016/S1474-4422(05)70141-1. View

Duval S, Tweedie R . Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics. 2000; 56(2):455-63. DOI: 10.1111/j.0006-341x.2000.00455.x. View

Rosenblum W . Fibrinoid necrosis of small brain arteries and arterioles and miliary aneurysms as causes of hypertensive hemorrhage: a critical reappraisal. Acta Neuropathol. 2008; 116(4):361-9. DOI: 10.1007/s00401-008-0416-9. View

Akoudad S, Wolters F, Viswanathan A, de Bruijn R, van der Lugt A, Hofman A . Association of Cerebral Microbleeds With Cognitive Decline and Dementia. JAMA Neurol. 2016; 73(8):934-43. PMC: 5966721. DOI: 10.1001/jamaneurol.2016.1017. View

Gottesman R, Albert M, Alonso A, Coker L, Coresh J, Davis S . Associations Between Midlife Vascular Risk Factors and 25-Year Incident Dementia in the Atherosclerosis Risk in Communities (ARIC) Cohort. JAMA Neurol. 2017; 74(10):1246-1254. PMC: 5710244. DOI: 10.1001/jamaneurol.2017.1658. View

Whelton P, Carey R, Aronow W, Casey Jr D, Collins K, Himmelfarb C . 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on.... Hypertension. 2017; 71(6):e13-e115. DOI: 10.1161/HYP.0000000000000065. View

Forette F, Seux M, Staessen J, Thijs L, Birkenhager W, Babarskiene M . Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet. 1998; 352(9137):1347-51. DOI: 10.1016/s0140-6736(98)03086-4. View

10.

Jansen P, Gribnau F, Schulte B, Poels E . Contribution of inappropriate treatment for hypertension to pathogenesis of stroke in the elderly. Br Med J (Clin Res Ed). 1986; 293(6552):914-7. PMC: 1341709. DOI: 10.1136/bmj.293.6552.914. View

11.

Saxby B, Harrington F, Wesnes K, McKeith I, Ford G . Candesartan and cognitive decline in older patients with hypertension: a substudy of the SCOPE trial. Neurology. 2008; 70(19 Pt 2):1858-66. DOI: 10.1212/01.wnl.0000311447.85948.78. View

12.

Jefferson A, Cambronero F, Liu D, Moore E, Neal J, Terry J . Higher Aortic Stiffness Is Related to Lower Cerebral Blood Flow and Preserved Cerebrovascular Reactivity in Older Adults. Circulation. 2018; 138(18):1951-1962. PMC: 6394409. DOI: 10.1161/CIRCULATIONAHA.118.032410. View

13.

Williamson J, Pajewski N, Auchus A, Bryan R, Chelune G, Cheung A . Effect of Intensive vs Standard Blood Pressure Control on Probable Dementia: A Randomized Clinical Trial. JAMA. 2019; 321(6):553-561. PMC: 6439590. DOI: 10.1001/jama.2018.21442. View

14.

de Leeuw F, de Groot J, Oudkerk M, Witteman J, Hofman A, van Gijn J . Hypertension and cerebral white matter lesions in a prospective cohort study. Brain. 2002; 125(Pt 4):765-72. DOI: 10.1093/brain/awf077. View

15.

Strandgaard S . Cerebral blood flow in the elderly: impact of hypertension and antihypertensive treatment. Cardiovasc Drugs Ther. 1991; 4 Suppl 6:1217-21. DOI: 10.1007/BF00114223. View

16.

. Global, regional, and national burden of Alzheimer's disease and other dementias, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2018; 18(1):88-106. PMC: 6291454. DOI: 10.1016/S1474-4422(18)30403-4. View

17.

Anderson C, Teo K, Gao P, Arima H, Dans A, Unger T . Renin-angiotensin system blockade and cognitive function in patients at high risk of cardiovascular disease: analysis of data from the ONTARGET and TRANSCEND studies. Lancet Neurol. 2010; 10(1):43-53. DOI: 10.1016/S1474-4422(10)70250-7. View

18.

Hughes D, Judge C, Murphy R, Loughlin E, Costello M, Whiteley W . Association of Blood Pressure Lowering With Incident Dementia or Cognitive Impairment: A Systematic Review and Meta-analysis. JAMA. 2020; 323(19):1934-1944. PMC: 7237983. DOI: 10.1001/jama.2020.4249. View

19.

Weiss J, Freeman M, Low A, Fu R, Kerfoot A, Paynter R . Benefits and Harms of Intensive Blood Pressure Treatment in Adults Aged 60 Years or Older: A Systematic Review and Meta-analysis. Ann Intern Med. 2017; 166(6):419-429. DOI: 10.7326/M16-1754. View

20.

Khatib R, Schwalm J, Yusuf S, Haynes R, Mckee M, Khan M . Patient and healthcare provider barriers to hypertension awareness, treatment and follow up: a systematic review and meta-analysis of qualitative and quantitative studies. PLoS One. 2014; 9(1):e84238. PMC: 3893097. DOI: 10.1371/journal.pone.0084238. View